SITC 30th Anniversary Annual Meeting (2015): Late Breaking Abstract Session INovember 6-8, 2015 Gaylord National Hotel & Convention Center National Harbor, MDSITC 30th Anniversary Annual Meeting Organizers Sandra Demaria, MD – Weill Cornell Medical College Madhav Dhodapkar, MD – Yale University Pamela S. Ohashi, PhD – Princess Margaret Cancer Centre Jennifer A. Wargo, MD – University of Texas MD Anderson Cancer Center Andrew D. Weinberg, PhD – Earle A. Chiles Research InstituteProgram SummaryLate Breaking Abstract Session focused on latest in coinhibition and costimulation at the SITC 30th Anniversary Annual Meeting on Friday, November 6, 2015 in National Harbor, MD. About the SITC 30th Anniversary Annual MeetingSITC's 30th Anniversary Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy research. The meeting consisted of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for both structured and informal discussions including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as ongoing SITC projects. Target AudienceThe target audience for this program included basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers that wished to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment. #AnnualMeeting #2015 #ClinicalTrials #Melanoma #Non-SmallCellLungCancer #RenalCellCarcinoma #PresentationSlides #Abstracts #SITC #CombinationTherapy #Durvalumab #Pembrolizumab #AdverseEvents #Toxicities #Clinician #Industry #Oncologist #Researcher #Video
Meeting: SITC 30th Anniversary Annual Meeting; Session: Late Breaking Abstract Session I; Presentation: Tumor Response from Durvalumab (MED14736) + Tremelimumab Treatment in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) is Observed Regardless of PD-L1 Status; Presenter: Naiyer A. Rizvi, MD – Columbia University Medical Center; Date: November 6, 201500:10:51
Meeting: SITC 30th Anniversary Annual Meeting; Session: Late Breaking Abstract Session I; Presentation: The PTEN Pathway in Tregs Fuctions as a Critical Driver of the Immunosuppressive Tumor Microenvironment and Tolerance to Apoptotic Cells; Presenter: David H. Munn, MD – Georgia Regents University Cancer Center; Date: November 6, 201500:13:03
Meeting: SITC 30th Anniversary Annual Meeting; Session: Late Breaking Abstract Session I; Presentation: Preliminary Results from a PhaseI/II Study of Epacadostat (incb024360) in Combination with Pembrolizumab in Patients with Selected Advanced Cancers; Presenters: Tara C. Gangadhar, MD – Abramson Cancer Center of the University of Pennsylvania; Date: November 6, 201500:09:25
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us